LY3410738   Click here for help

GtoPdb Ligand ID: 12340

Synonyms: example 2 [US11001596B2] | LY-3410738
Compound class: Synthetic organic
Comment: LY3410738 is a clinical stage orally bioactive, covalent mutant isocitrate dehydrogenase (IDH1) inhibitor [2]. It was developed for potential to treat cancers that are driven by the oncometabolite 2-hydroxyglutarate (2-HG) that is generated by mutated IDH1.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 1
Rotatable bonds 10
Topological polar surface area 90.9
Molecular weight 504.28
XLogP 3.84
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C=CC(=O)N1CCN(CC1)[C@H](c1ccc(cc1)[C@@H](Nc1ncc2c(n1)N(CC)C(=O)OC2)C)CC1CC1
Isomeric SMILES CCN1c2nc(ncc2COC1=O)N[C@@H](C)c1ccc(cc1)[C@H](CC1CC1)N1CCN(CC1)C(=O)C=C
InChI InChI=1S/C28H36N6O3/c1-4-25(35)33-14-12-32(13-15-33)24(16-20-6-7-20)22-10-8-21(9-11-22)19(3)30-27-29-17-23-18-37-28(36)34(5-2)26(23)31-27/h4,8-11,17,19-20,24H,1,5-7,12-16,18H2,2-3H3,(H,29,30,31)/t19-,24-/m0/s1
InChI Key AFGYODUJVVOZAX-CYFREDJKSA-N
Bioactivity Comments
LY3410738 inhibits the activity of mutant IDH1 in vitro and in vivo, and mediates the predicted reduction in 2-HG production. It does not alter the physiological function of wild-type IDH1.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
isocitrate dehydrogenase (NADP(+)) 1 Hs Inhibitor Inhibition 7.0 – 8.2 pIC50 - 1
pIC50 8.2 (IC50 6.27x10-9 M) [1]
Description: Inhibition of hIDH1 with R132H mutation
pIC50 7.0 (IC50 1.05x10-7 M) [1]
Description: Inhibition of WT hIDH1
isocitrate dehydrogenase (NADP(+)) 2 Hs Inhibitor Inhibition 6.1 pIC50 - 1
pIC50 6.1 (IC50 8.84x10-7 M) [1]
Description: Inhibition of WT hIDH2